fPBA-coumarin probe [2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-5-(3-(4-methyl-2-oxo-2H-chromen-7-yloxy)propoxy)benzaldehyde (6) 
General
fPBA and Sal were obtained from Aldrich or Acros and used as received. BSA (Bovine serum albumin-fraction V) was purchased from Rockland. All NMR spectra were collected and processed on a Bruker Avance III 600 NMR Spectrometer at 298 K unless otherwise noted. 1 H and 13 C NMR spectra were referenced to DMSO (2.50 and 39.51 ppm, respectively). 11 B was referenced to BF 3 .Et 2 O (0.00 ppm) by the instrument's software; accuracy of the chemical shift determination was confirmed by measuring a spectrum of 5 with boric acid in D 2 O as an internal standard. NOE measurements were obtained from 2D NOESY. One-bond 1 H-13 C correlations were determined by HSQC, and twothree-bond were measured by HMBC experiments. 1 H-15 N connectivities were obtained by HMBCGP-15 N.
Multiplicities are indicted by s (singlet), d (doublet), t (triplet), q (quartet), and m (multiplet). Chemical shifts are reported in parts per million (ppm). Accurate mass data was obtained using a Waters (Waltham, MA USA) Time-ofFlight mass spectrometer model LCT Premier. The instrument was operated in positive ion W mode with a mass resolution of 10K. Ions were generated in ESI mode using a Z-spray ion source. Samples were flow-injected into a solvent stream consisting of 1:1 water:acetonitrile with 0.2% formic acid. Accurate masses were obtained using internal mass standards and data was processed with MassLynx 4.1 software.
Kinetics
Kinetics were measured at 25 C in 0.1 M sodium phosphate (pH 7.0) using a Hewlett-Packard 8453 diode array absorption spectrophotometer or a Hewlett-Packard 8452A diode array absorption spectrophotometer equiped with Olis GlobalWorks software. A dual chambered cuvette was used to obtain absorption difference spectra as a function of time. Briefly, equal volumes of each solution were placed into the chambers of the cuvette. The instrument was zeroed and collection of kinetics commenced. After checking the baseline the cuvette was removed, rapidly mixed by inversion and replaced in the instrument. Spectra were collected at the indicated time intervals until no additional change in the spectrum was observed. For the reaction of salicylaldehyde (Sal) with p-hydrazinylbenzoic acid (HBA), the change in absorption at a particular wavelength as a function of time was extracted from these data and plotted using Sigmaplot. The data of absorbance vs. time for Sal -HBA were fit to a single exponential and an apparent second order rate constant was calculated. The data of absorbance spectra vs. time for fPBA-HBA were collected and analysed using Olis GlobalWorks software. Inset: apparent second order rate constant.
Kinetic data for fPBA-HBA were collected in a similar manner, except that the concentrations of the reagents were lower as noted in the text and data points were collected every 0.5 to 1.2 seconds.
Figure S2:
Absorption spectra of 100 M fPBA, 100 M HBA and the product of the reaction of the two components (100 M final concentration).
Figure S3:
A. Kinetic data for fPBA-HBA under second order conditions as a function of concentration. fPBA was allowed to react with HBA (25, 50, 75 and 100 M final concentration) at 25 C in pH 7.0 buffer. The progress of the reaction was monitored using absorption difference spectroscopy. The change in absorption at 350 nm is plotted as a function of time for each sample. Yellow: 100 M, green: 75 M, red: 50 M, black: 25 M. B. The data from panel A are normalized to the highest absorption value for the 100 M trace to illustrate the lack of concentration dependence of the decrease at 350 nm. Note that the initial curvature of the data varies with concentration, indicative of higher order kinetics for the first step of the process.
A

Figure S4:
Absorption difference spectrum of 100 M HBA + 5 M fPBA as a function of time in 0.1 M sodium phosphate buffer, pH 7.0, 25 C. Spectra were collected at 1 s interval; 9 second intervals shown for clarity.
Test of stability
Equal volumes of solutions containing 5 mM fPBA amd 5 mM HBA in 0.1 M sodium phosphate buffer, pH 7.0, containing 10% D 2 O were mixed and added to the NMR tube. An internal standard (n-butanol in 90% buffer and 10% D 2 O) in a capillary tube was inserted into the tube. The proton NMR spectrum of the sample was measured. The sample was allowed to remain in the NMR tube on a lab bench and the spectrum was collected periodically over a period one month. The initial spectrum and the spectrum after one month is illustrated (page S18).
Tests of orthogonality
The effect of other functional groups on the kinetics of fPBA + HBA were assessed by making stock solutions of fPBA in pH 7 buffer containing 2x the desired concentration of the additive. [Final concentrations: Lysine, 1 mM; glutathione, 5 mM; glucose, 10 mM] Kinetics of DAB formation was observed by absorption difference spectroscopy as described above. Subsequently, the same stock solutions of fPBA (without additive) were used with same solution of HBA and the reaction was again observed by absorption difference spectroscopy. A typical result is shown below: 
-(4'-carboxyphenyl)-1-hydroxy-2,3,1-benzodiazaborine (5))
A round bottom flask was charged with 2fPBA (0.213 mmol), distilled water (2 mL), and a HBA (0.320 mmol). A white solid was formed immediately in the solution. The reaction mixture was stirred at room temperature for 10 min. The solid was collected by centrifugation and was washed once with distilled water. The resulting product was dried by a stream of nitrogen for 18-24 hours.
No attempt was made to optimize the yield of this preparation. The reaction was confirmed to form a single product in aqueous solution by mixing the individual components in a 1:1 molar ratio and obtaining NMR spectra immediately after mixing. This process was performed in both water and 0.1 M phosphate buffer, pH 7.0, with identical results.
1,2-Dihydro-2-(4'-carboxyphenyl)-1-hydroxy-2,3,1-benzodiazaborine (5) 
S4
The fluorophore-fPBA conjugate was prepared following the scheme above.
2-Bromo-5-hydoxybenzaldehyde (S1) :
To a suspension of 3-hydroxybenzaldehyde (8 g, 65.6 mmol) in methylene chloride (100 mL) in an ice bath was added bromine (1.5eq, 5 ml) slowly over one hour. The solution was allowed to rise to room temperature, and then the mixture was stirred for 4 hours. 
2-Bromo-5-(3-bromopropoxy)benzaldehyde (S2):
To a solution of S1 (0.5 g, 2.5 mmol) in DMF (10 mL) was added NaOH (1 eq, 0.1 g, 2.5 mmol) at room temperature. The mixture was stirred until all the NaOH was dissolved (1 hour). This solution was added slowly into 1,3-dibromopropane (2.8 eq, 0.7 mL, 6.9 mmol) in DMF (15 ml). The reaction was stirred for 12 hours at room temperature. Aqueous HCl was added to the solution (1 M, 5 mL),, which was then (1 M, 5 mL), diluted with water (10 mL), and extracted with diethyl ether. After column chromatography (silica gel, CH 2 Cl 2 /hexanes 3:1), a white solid was collected 5, 156.3, 132.61, 131.95, 121.16, 116.05, 111.57, 63.91, 30.08, 27 .74.
7-Hydroxy-4-methylcoumarin (S3):
Compound S3 was prepared by the Pechmann condensation using resorcinol and ethyl acetoacetate. The 1 H and 13 C NMR spectra matched those published for the commercially available material.
2-Bromo-5-(3-(4-methyl-2-oxo-2H-chromen-7-yloxy)propoxy)benzaldehyde (S4):
At room temperature, to a solution of bromide S2 (0.8 g, 2.5 mmol) in DMF (10 mL) was added NaOH powder (1eq, 0.102 g, 2.55 mmol) and the mixture was stirred for 1 hour until all NaOH was dissolved in DMF. This mixture was added to a solution of coumarin S3 (0.448 g, 2.54 mmol) in DMF (20 mL) slowly over a period of 1 hour. After stirring for another 6 hours, the reaction was quenched by addition of aqueous HCl (4 M, 10 mL), diluted with distilled water (10 mL), and extracted with diethyl ether. The crude oil product was purified by column chromatography (silica gel, ethyl acetate:hexanes 2:3) and a white solid was isolated (0.24 g, 39% yield). 161.5, 158.6, 155.5, 152.7, 134.9, 134.2, 125.8, 123.7, 118.4, 114.0, 113.5, 112.8, 112.3, 101.7, 65.0, 64.9, 29.1, 18.9 . 161.87, 161.28, 160.49, 155.29, 152.48, 143.30, 136.96, 125.55, 120.19, 113.70, 112.58, 112.05, 111.13, 101.53, 72.51, 64.88, 64.25, 28.96, 21.88, 18.66. 11 08, 161.53, 161.09, 160.10, 154,.73, 153.36, 153.36, 150.27, 139.76, 136.90, 133.74, 129.51, 126.47, 123.45, 118.35, 113.18, 112.40, 111.16, 109.84, 101.29, 65.05, 64.38, 28.36, 18.08 65, 161.63, 150.39, 150.36, 132.71, 112.07, 25.65, 25.22, 16 .01.
H NMR (CDCl
Protein labeling
BSA (final concentration 40 µM) was allowed to react with ~100 fold excess of the crosslinker 7 for samples stored for at least one month. The fluorophore, fPBA-coumarin 6, was dissolved in DMSO and its concentration was determined spectrophotometrically using an extinction coefficient of 24000 M -1 cm -1 at 320 nm. The hydrazine-BSA or unmodified BSA (final concentration 25 µM) was allowed to react by continuous mixing with 75 M of 6 for 15 min at room temperature in phosphate buffer (10 mM, pH 7.0).
The final concentration of DMSO in the samples was 2 % (v/v). The protein samples were subjected to rapid gel filtration chromatography using spin columns to remove unreacted fluorophore. Absorption and emission spectra of each sample (equal protein concentration) were obtained using a BioTek Synergy Mx plate reader. The absorption and emission spectra of protein samples (BSA and BSA-hydrazine) that were not treated with fluorophore were also obtained as additional controls. The fluorophore treated protein samples were subjected to SDS-PAGE analysis. The gel was photographed using a handheld long wavelength UV lamp for illumination. The same gel was Coomassie stained for protein, destained using acetic acid/methanol/water and then photographed under white light. 
